Neglecting the neglected: Tobacco cessation support is essential for the management of asthma and COPD

Asthma and COPD management have a broad framework, and smoking cessation plays an essential role. We examine the management of asthma and COPD patients not only for inhaler treatment options but also for essential interventions, such as smoking cessation support. Data were collected cross-sectionall...

Full description

Saved in:
Bibliographic Details
Published inTobacco induced diseases Vol. 22; no. January; pp. 1 - 8
Main Authors Karadoğan, Dilek, Kaya, İlknur, Yumrukuz Şenel, Merve, Konyalıhatipoğlu, Esin Bilgin, Telatar, Tahsin Gökhan, Akgün, Metin
Format Journal Article
LanguageEnglish
Published Greece European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 01.01.2024
European Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Asthma and COPD management have a broad framework, and smoking cessation plays an essential role. We examine the management of asthma and COPD patients not only for inhaler treatment options but also for essential interventions, such as smoking cessation support. Data were collected cross-sectionally from pulmonology departments of three government hospitals in Türkiye between May and September 2022. Patients aged ≥18 years who had been diagnosed with asthma or COPD for at least a year, were included in the study. The demographic and clinical characteristics of the patients were investigated. Routine cessation interventions were implemented for current smokers, and they were followed via phone calls after one month regarding their quit status and access to cessation clinics. Data from 145 patients with asthma and 148 patients with COPD were analyzed. The rate of current smoking among patients with asthma and COPD was 18.8% and 34.5%, respectively. Current smoking was negatively associated with age (<65 years) and disease duration (years) for both diseases (p<0.05). In addition, for asthmatics, presence of pulmonary disease in the family (OR:0.28, 95% CI: 0.10-0.79) and for COPD patients presence of hospitalization (OR: 0.26, 95% CI: 0.07-0.93) were negatively associated with current smoking. After one month, 85.1% of current asthmatic smokers had not tried to call a quitline, while 14.8% had tried to contact a quitline. Among current smoker COPD patients, only 1.9% had visited a smoking cessation clinic. Tobacco cessation support seems to be neglected in asthma and COPD management. Instead, pulmonologists and patients focus on pharmaceutical treatments, which constitute the other component of care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1617-9625
2070-7266
1617-9625
DOI:10.18332/tid/176228